CARDINAL HEALTH, INC.

Lobbying for CARDINAL HEALTH INC

Amended

The filer submitted a later report covering this same period, so the amounts here have been replaced. Site totals count only the latest version. See the current filing, posted Oct 22, 2025.

Filing Q2 report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 21, 2025

Expenses

$420,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

Ohio

Official filing document

Government bodies contacted 7

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 5

Health Issues

Issues related to drug pricing, pharmacies, provider status, biosimilars, cell and gene therapy, food is medicine; Issues related to provider reimbursement, Medicare and Medicaid, workforce shortages, and product shortages.

Manufacturing

Education on supply chain issues, drug shortages, domestic manufacturing, medical device environmental issues; Issues related to the medical supply chain and transportation.

Taxation/Internal Revenue Code

Issues related to tax reform and 2017 Tax Cuts and Jobs Act.

Trade (domestic/foreign)

Issues related to tariffs, trade, and U.S. trade policy.

Tariff (miscellaneous tariff bills)

Issues related to tariffs, trade, and U.S. trade policy.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.